Lupin share price slipped in trade after the company announced that United States Food and Drug Administration (USFDA) has ...

Mumbai: Lupin has announced that the US Food and Drug Administration (U.S. FDA) has completed a Pre-Approval Inspection with ...

Usage of generic medicines has been increased as they became boon to the poor and middle-class people because they are ...

Lynette Abbott and Hira Shaukat from The University of Western Australia, provide insights into research on enhancing health ...

Lupin Ltd share price was down by -5.75% from ... Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here ...

Hepatitis Treatment market size reached a valuation of USD 22.2 billion in 2023 and is expected to grow at a CAGR of 3.5% through the forecast period. The market is primarily driven by the rising ...

Report Ocean has published a new report on the India Omega-3 Supplements Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report ...

Sensex, Nifty, Share Prices Highlights: Benchmark domestic indices BSE Sensex and NSE Nifty 50 ended in positive territory on ...

GIFT Nifty was trading down 17 points or 0.07% at 25,0094, indicating a muted start for the domestic indices NSE Nifty 50 and ...

Nifty Index opened positive and while it moved up in the first couple of hours, it sank for the rest of the session. It took ...

Axis Securities has overweight call on Lupin with a target price of Rs 2,500. The current market price of Lupin is Rs 2,216. We have always had a Bankruptcy Act to allow a company to allow its ...